胰岛因子1在胰腺中的转录调控机制CSCD

胰岛因子1(ISL1)是重要的转录因子,在胚胎发育期广泛分布于全身多种组织细胞,而在成体组织中主要表达于胰岛和神经组织。在胰腺中,ISL1主要调控胰岛素、胰高血糖素、生长抑素、胰多肽等内分泌激素的表达,在胚胎期促进胰腺背侧间充质细胞和胰岛内分泌细胞的分化、发育、成熟,在出生后通过抑制细胞凋亡、促进细胞增殖来维持胰岛β细胞数量的稳态。ISL1通过与基因启动子上的特定元件TAAT/ATTA结合,并与其它蛋白质相互作用,实现对下游靶基因的转录调控,以完成多种生理功能。     

胰岛因子1在胰腺中的转录调控机制

胰岛因子1(ISL1)是重要的转录因子,在胚胎发育期广泛分布于全身多种组织细胞,而在成体组织中主要表达于胰岛和神经组织。在胰腺中,ISL1主要调控胰岛素、胰高血糖素、生长抑素、胰多肽等内分泌激素的表达,在胚胎期促进胰腺背侧间充质细胞和胰岛内分泌细胞的分化、发育、成熟,在出生后通过抑制细胞凋亡、促进细胞增殖来维持胰岛β细胞数量的稳态。ISL1通过与基因启动子上的特定元件TAAT/ATTA结合,并与其它蛋白质相互作用,实现对下游靶基因的转录调控,以完成多种生理功能。     

胰岛素增强子结合蛋白-1(ISL1)与肿瘤的发生与发展北大核心CSCD

在人类发育过程中,胰岛素增强子结合蛋白-1(ISL1)被认为是一个胚胎性基因。成年后,ISL1只在特定的组织或器官中表达,例如胰腺和大脑。近年来,在多种肿瘤中检测到ISL1的异常表达,不仅在胰腺内分泌肿瘤、神经肿瘤中高表达(与之相应的正常组织也表达ISL1),而且在淋巴瘤、胃癌和膀胱癌等肿瘤组织中呈现表达(其正常组织不表达ISL1)。ISL1的异常表达可能与肿瘤的发生发展及预后相关。本文针对ISL1与肿瘤的相关性以及在肿瘤发生发展中的功能进行综述,为进一步的分子机制研究提供理论依据。     

胰岛素增强子结合蛋白-1（ISL1）与肿瘤的发生与发展

在人类发育过程中,胰岛素增强子结合蛋白-1(ISL1)被认为是一个胚胎性基因。成年后,ISL1只在特定的组织或器官中表达,例如胰腺和大脑。近年来,在多种肿瘤中检测到ISL1的异常表达,不仅在胰腺内分泌肿瘤、神经肿瘤中高表达（与之相应的正常组织也表达ISL1）,而且在淋巴瘤、胃癌和膀胱癌等肿瘤组织中呈现表达（其正常组织不表达ISL1）。ISL1的异常表达可能与肿瘤的发生发展及预后相关。本文针对ISL1与肿瘤的相关性以及在肿瘤发生发展中的功能进行综述,为进一步的分子机制研究提供理论依据。     

ISL1调控细胞生物学行为的分子机制研究进展

胰岛素增强子结合蛋白-1(insulin gene enhancer binding protein-1,ISL1)是一种含两个LIM结构域和一个HD(homeodomain)结构域的转录因子,已被证明能调节多种信号通路和生物进程。在正常组织细胞中,ISL1通过与多个转录因子相互作用来精确调控靶基因表达从而促进细胞的分化、增殖等生物学过程。在肿瘤细胞中,ISL1通过影响细胞增殖和转移以及其他细胞过程最终在癌症的发生和发展中发挥作用。该文回顾ISL1参与的调控网络如何影响细胞增殖和肿瘤发生,细胞分化,细胞迁移、侵袭和转移,细胞凋亡。在不同的细胞中,ISL1的表达受不同的蛋白信号调控,并与不同的分子协同作用对细胞生物进程产生相应的影响,通过探究与ISL1功能相关的蛋白和信号通路,揭示正常组织发育和疾病的发生发展规律,为进一步机制研究提供理论基础,也可为新药开发、临床诊断提供理论依据。     

生长因子Progranulin的结合受体和生物学功能

生长因子颗粒素蛋白前体（progranulin, PGRN）广泛存在于动物和植物组织中.研究证明,哺乳动物的PGRN是一个多功能分子,在组织/器官发育、细胞分化、肿瘤发生发展、炎症应答以及神经退行性疾病中均具有重要的作用.PGRN发挥生物学功能需要和多种结合蛋白相互结合,例如sortilin、Toll样受体9（TLR9）、肿瘤坏死因子受体（TNFR）及分泌性淋巴细胞蛋白酶抑制因子（SLPI）等. 本文将对PGRN的结合受体和生物学功能进行综述.     

核转录因子Yin Yang-1在肿瘤中的研究进展

Yin Yang-1(YY1)属于GLI-Krüppel转录因子家族,其基因进化保守,在人类多种组织中广泛表达。YY1参与多种基本生物学过程如胚胎形成、染色质重塑、细胞组织分化等,具有非常复杂的功能机制。YY1基因敲除后的小鼠胚胎期死亡。近年来有关YY1在肿瘤发生及治疗中作用的研究报道很多,我们对YY1在肿瘤中的表达,及其在肿瘤发生、侵袭转移、治疗中的作用和机制进行简要综述。     

血红素加氧酶-1在肿瘤中的表达及生物学功能

血红素加氧酶-1(HO-1)是血红素分解代谢的关键酶,是一种广泛存在于人体各组织器官的抗氧化防御酶,在多种刺激条件下发挥抗氧化、抗炎及抑制细胞凋亡等重要生物学作用。近年研究发现,HO-1在多种人体肿瘤组织中表达增强,参与肿瘤血管生成、增殖、转移等多种生物学过程,与肿瘤的发生发展密切相关。同时,HO-1在化疗、放疗等应激条件下表达上调,可增强肿瘤的耐药性,使肿瘤对治疗的敏感性降低。我们简要综述HO-1在肿瘤中的表达及其对肿瘤发生、发展的影响。     

大鼠心肌虚血再灌流后肝细胞再生因子的表达变化

肝细胞再生因子（hepatocyte growth factor, HGF）对多种细胞都具有促进增殖及运动、抗凋亡的作用,对组织器官的发育形成也起到重要作用．在肝脏、肾脏、肺、心脏等器官受损之后的修复过程中,有积极的促进再生的作用．本研究采用了心虚血再灌流大鼠模型,发现心肌细胞受损伤后 6 h 血清中HGF水平显著增高．在比较了肾脏、肺、肝脏、脾脏等组织提取液中HGF的含量之后,发现心虚血再灌流手术后,肾脏、肺、肝脏中HGF的含量变化不明显,而脾脏的提取液中HGF的含量增加显著．对脾脏组织的连续切片进行HGF与血管内皮细胞的特异性标志物von Willanbrand Factor (vWF)免疫组织化学染色研究,发现手术后脾脏中产生HGF的细胞主要为血管内皮细胞．此项研究首次阐明组织器官受损后,远端组织器官的血管内皮细胞能够增加HGF的合成和分泌,增加的HGF通过体液循环到达受损组织器官,促进其修复再生．     

纤维化疾病中的机械敏感性离子通道Piezo1

Piezo1是哺乳动物中新发现的一种机械敏感(mechanosensitive,MS)离子通道,在不同组织和器官中发挥着重要功能,包括骨骼、泌尿道、眼球和动脉等。然而,异常的Piezo1机械传导会造成多种疾病的发生并促进病程的发展。纤维化疾病几乎可以发生在任何一个组织和器官中,其主要特征是胶原蛋白和其他细胞外基质(extracellular matrix,ECM)成分的过度交联与累积,最终导致组织器官刚度增加,生理功能受到影响。目前,越来越多的研究表明,Piezo1在纤维化疾病的发生和发展中扮演着重要的调控作用,与其基质力学状态变化有着密切联系。本文叙述了Piezo1的结构和激活机理,并且系统地总结了Piezo1在心、肾、胰和肝等多种器官纤维化疾病中的研究进展,以期为纤维化疾病的治疗提供新的视角和策略。     

Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling

Isoliquiritigenin (ISL, 4,2′,4′-trihydroxychalcone), which is found in licorice, shallot and bean sprouts, is a potent antioxidant with anti-inflammatory and anti-carcinogenic effects. The purpose of this study was to investigate the effects of ISL treatment on the migration, invasion and adhesion characteristics of DU145 human prostate cancer cells. DU145 cells were cultured in the presence of 0–20 μmol/L ISL with or without 10 μg/L epidermal growth factor (EGF). ISL inhibited basal and EGF-induced cell migration, invasion and adhesion dose dependently. ISL decreased EGF-induced secretion of urokinase-type plasminogen activator (uPA), matrix metalloproteinase (MMP)-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), and vascular endothelial growth factor (VEGF), but increased TIMP-2 secretion in a concentration-dependent manner. In addition, ISL decreased the protein levels of integrin-α2, intercellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM), and mRNA levels of uPA, MMP-9, VEGF, ICAM and integrin-α2. Furthermore, basal and EGF-induced activator protein (AP)-1 binding activity and phosphorylation of Jun N-terminal kinase (JNK), c-Jun and Akt were decreased after ISL treatment. However, phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and p38 mitogen-activated protein kinase was not altered. The JNK inhibitor SP600125 inhibited basal and EGF-induced secretion of uPA, VEGF, MMP-9 and TIMP-1, as well as AP-1 DNA binding activity and cell migration. These results provide evidence for the role of ISL as a potent antimetastatic agent, which can markedly inhibit the metastatic and invasive capacity of prostate cancer cells. The inhibition of JNK/AP-1 signaling may be one of the mechanisms by which ISL inhibits cancer cell invasion and migration.     

ISL1与PHF8相互作用促进小鼠胚胎干细胞向心肌细胞的分化

近年的研究发现,在心肌细胞分化过程中,转录因子可以与表观修饰蛋白质结合进行更为精细的转录调控.作为转录因子的胰岛素基因增强子结合蛋白1（islet1, ISL1）,在心血管发育过程中发挥至关重要的作用.然而, ISL1是否能够与表观修饰蛋白质相互作用,从而发挥更为精细的调控作用,目前尚未明确.本室研究发现,ISL1在小鼠胚胎干细胞向心肌细胞分化过程中,能够与组蛋白去甲基化酶PHD指蛋白8(PHF8)相互作用从而促进分化. 实时RT-PCR和Western 印迹的方法检测显示,ES细胞向心肌细胞分化过程中ISL1和PHF8具有相似的表达谱.通过免疫共沉淀的方法检测分化过程中ISL1与PHF8的结合,通过染色质免疫沉淀的方法对二者在ISL1下游靶基因增强子区的结合水平进行检测,利用实时RT-PCR检测二者的相互结合对心肌细胞分化的影响.结果显示,ISL1能够与PHF8相互作用,共同结合在ISL1下游靶基因Mef2c和Myocd的增强子区,协同促进ES细胞向心肌细胞的分化.本研究证实,在心肌细胞分化过程中,ISL1存在与表观修饰蛋白质PHF8的相互作用,从而进一步促进心肌细胞的分化.     

Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction

Glutamate-mediated excitotoxicity, which is associated with reactive oxygen species (ROS), is hypothesized to be a major contributor to pathological cell death in the mammalian central nervous system, and to be involved in many acute and chronic brain diseases. Here, we showed that isoliquiritigenin (ISL) isolated from Glycyrrhiza uralensis (Gu), one of the most frequently prescribed oriental herbal medicines, protected HT22 hippocampal neuronal cells from glutamate-induced oxidative stress. In addition, we clarified the molecular mechanisms by which it protects against glutamate-induced neuronal cell death. ISL reversed glutamate-induced ROS production and mitochondrial depolarization, as well as glutamate-induced changes in expression of the apoptotic regulators Bcl-2 and Bax. Pretreatment of HT22 cells with ISL suppresses the release of apoptosis-inducing factor from mitochondria into the cytosol. Taken together, our results suggest that ISL may protect against mitochondrial dysfunction by limiting glutamate-induced oxidative stress. In conclusion, our results demonstrated that ISL isolated from Gu has protective effects against glutamate-induced mitochondrial damage and hippocampal neuronal cell death. We expect ISL to be useful in the development of drugs to prevent or treat neurodegenerative diseases.     

Ultrastructural and immunocharacterization of undifferentiated myocardial cells in the developing mouse heart

The recent discovery of several myogenic cardiac progenitor cells in the post-natal heart suggests that some myocardial cells may remain undifferentiated during embryonic development. In this study, we examined the subcellular characteristics of the embryonic (E) mouse ventricular myocardial cells using transmission electron microscopy (TEM). At the ultrastructural level, we identified three different cell populations within the myocardial layer of the E11.5 heart. These cells were designated as undifferentiated cells (43 +/- 6%), moderately differentiated cells (43 +/- 2%) and mature cardiomyocytes (14 +/- 4%). Undifferentiated cells contained a large nucleus and sparse cytoplasm with no myofibrillar bundles. Moderately differentiated cells contained randomly arranged myofilaments in the cytoplasm. In contrast, mature cardiomyocytes contained well-developed sarcomere structures. We also confirmed the presence of similar undifferentiated cells albeit at low levels in the E16.5 ( approximately 20%) and E18.5 ( approximately 7%) myocardium. Further we used immunogold labeling technique to test whether these distinct cell populations were also positive for markers such as Nkx2.5, ISL1 and ANF. A preponderance of anti-Nkx2.5 label was found in the undifferentiated and moderately differentiated cell types. Anti-ANF label was found only in the cytoplasmic compartment of moderately differentiated and mature myocardial cells. All of the undifferentiated cells were negative for anti-ANF labeling. We did not find immuno-gold labeling with ISL1 in any of the three myocardial cell types. Based on these results, we suggest that embryonic myocardial cell differentiation is a gradual process and undifferentiated cells expressing Nkx2.5 in post-chamber myocardium may represent a progenitor cell population while cells expressing Nkx2.5 and ANF represent differentiating myocytes.